SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-18-159368
Filing Date
2018-05-10
Accepted
2018-05-10 17:16:45
Documents
8

Document Format Files

Seq Description Document Type Size
1 FINAL PROSPECTUS d414240d424b3.htm 424B3 3894946
2 GRAPHIC g414240g04l02.jpg GRAPHIC 114438
3 GRAPHIC g414240g05u18.jpg GRAPHIC 71998
4 GRAPHIC g414240g06u90.jpg GRAPHIC 50040
5 GRAPHIC g414240g16n86.jpg GRAPHIC 177293
6 GRAPHIC g414240g62z74.jpg GRAPHIC 49383
7 GRAPHIC g414240g72b50.jpg GRAPHIC 100911
8 GRAPHIC g414240g83x16.jpg GRAPHIC 106918
  Complete submission text file 0001193125-18-159368.txt   4820890
Mailing Address C/O IMPAX LABORATORIES, INC. 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 510-240-6000
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-224702 | Film No.: 18824033
SIC: 2834 Pharmaceutical Preparations